| Nombre | JOSE SULIVAN LOPEZ GONZALEZ |
|---|---|
| Área | BIOLOGÍA Y QUÍMICA |
| Campo | CIENCIAS DE LA VIDA |
| Disciplina | INMUNOLOGÍA |
| Especialidad | INMUNOBIOLOGIA |
| CVU | 9183 |
| Institución | |
|---|---|
| Dependencia | SIN INFORMACIÓN |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 2 |
| Vigencia | Inicio: 01/01/2023 |
| Fin: 31/12/2027 |
Publicaciones ORCID
- 2026
- Evaluation and Comparison of Treatment with Polymerised Collagen or Pirfenidone as Stand-Alone Therapy on the Production of Profibrotic Factors in Tracheal Stenosis and Tracheal Anastomosis Scarring After Resection International Journal of Molecular Sciences
- Glyoxalase‐1 Inhibition Leads to Ferroptosis Induction in Lung Cancer Cells: A Dual Mechanism of Action of Hydroxamic Acids Derived from Cysteine ChemMedChem
- 2025
- Circulating miRNAs are Down-regulated in Asthmatic Patients; Case-control Study International Journal of Medical Sciences
- Alchemical free energy-based optimization of quinazoline derivatives as potent EGFR inhibitors with cytotoxic activity Bioorganic & Medicinal Chemistry
- A Comprehensive Review of Long Non-Coding RNAs in the Cancer–Immunity Cycle: Mechanisms and Therapeutic Implications International Journal of Molecular Sciences
- 2024
- SOCS1 Inhibits IL-6-Induced CD155 Overexpression in Lung Adenocarcinoma International Journal of Molecular Sciences
- Transcriptomic Analysis Reveals Early Alterations Associated with Intrinsic Resistance to Targeted Therapy in Lung Adenocarcinoma Cell Lines Cancers
- 2022
- The systemic-level repercussions of cancer-associated inflammation mediators produced in the tumor microenvironment Frontiers in Endocrinology
- 2021
- miRNAs, from Evolutionary Junk to Possible Prognostic Markers and Therapeutic Targets in COVID-19 Viruses
- Role of HMGB1 in Cisplatin-Persistent Lung Adenocarcinoma Cell Lines Frontiers in Oncology